Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

558 results about "Amino acid mutation" patented technology

A mutation is any random change in the DNA. The sequence of amino acids is critical to the performance of a protein; even a single amino acid in the wrong place can cause an enzyme to be non-functional or cause a disease such as Sickle Cell Anemia.

Brazilian sweet protein mutant and application thereof

The invention belongs to the technical field of protein engineering, and discloses a Brazilian sweet protein mutant and application thereof. According to the invention, lysine is used for replacing aspartic acid at the 29th site of Brazilian sweet protein, and / or arginine is used for replacing glutamic acid at the 36th site, and / or alanine is used for replacing aspartic acid at the 50th site, amino acid mutation at the sites is carried out to construct a Brazilian sweet protein mutant, and the Brazilian sweet protein mutant is subjected to heterologous expression in pichia pastoris GS115, so that the Brazilian sweet protein mutant is obtained. And carrying out sweetness performance evaluation on the expressed Brazilian sweet protein mutant. The sweetness property of the double mutant Asp29Lys-Asp50Ala protein is improved by 240% compared with the sweetness property of the Brazilian sweet protein before mutation.
Owner:NANJING TECH UNIV

Tyrosine ammonia lyase mutant and application thereof in synthesis of p-coumaric acid

The embodiment of the invention provides a tyrosine ammonia lyase mutant and application thereof in synthesis of p-coumaric acid. The mutant is subjected to any one of the following amino acid mutations on an amino acid sequence as shown in SEQ ID NO. 2: F497I, F497I + L248M, F497I + L248M + M4T, and L248M + F497I + M4T + V482L. According to the embodiment of the invention, an amino acid sequence as shown in SEQ ID NO. 2 is taken as a template, a key active site of the template is subjected to mutation transformation, a mutant library is constructed, and a series of mutants with remarkably improved catalytic activity and / or conversion rate are screened; the tyrosine ammonia lyase mutant provided by the embodiment of the invention can selectively catalyze L-tyrosine to generate p-coumaric acid, and has excellent yield and / or higher yield.
Owner:SOUTH CHINA UNIV OF TECH

Sweet protein mutant as well as preparation method and application thereof

The invention provides a sweet protein mutant as well as a preparation method and application thereof. The mutant is obtained by amino acid mutation on the basis of an amino acid sequence as shown in SEQ ID NO.1 of sweet protein. The amino acid mutation type comprises at least one of K5D, V7R, D29N or E53R. The mutation is introduced into the amino acid sequence of the sweet protein, so that compared with the sweet protein corresponding to the original sequence, the sweetness of the mutant is obviously improved.
Owner:KINGDOMWAY BIOTECH (JIANGSU) CO LTD +2

Milk-derived broad-spectrum antibacterial peptide and application thereof

The invention discloses a milk-derived broad-spectrum antibacterial peptide and application thereof, and relates to the technical field of biology. The amino acid sequence of the antibacterial peptide is as shown in any one of SEQ ID NO.2-6. Five novel antibacterial peptides are obtained by carrying out symmetrical structure design and amino acid mutation on the basis of a template peptide, and tests find that the five novel antibacterial peptides have broad-spectrum antibacterial activity which is obviously higher than that of the template peptide, and basically have no cytotoxicity. Wherein the geometric mean (GM) of the minimum inhibitory concentration can reach 3.60, and the therapeutic index (TI) can reach 71.11. The antibacterial peptide prepared by the invention still keeps good antibacterial activity in physiological salt concentration and protease environment, has certain serum stability, and has higher application value; in addition, the antibacterial peptide has a good inhibition effect on the formation of a bacterial biofilm, and has a synergistic effect with traditional antibiotics.
Owner:GUIYANG UNIV

PANX3 biological pore protein and application of mutant and single molecule detection thereof

The invention belongs to the technical field of characterization of target samples, and provides PANX3 biopore protein and application of a mutant and single molecule detection thereof. The PANX3 biopore protein is composed of seven identical subunits, the overall channel is funnel-shaped, and the amino acid sequence is shown as SEQ ID NO: 1. After one or more amino acids of the wild type PANX3 biopore protein are mutated into common amino acids except original amino acids, compared with the wild type PANX3 biopore protein, the mutant can be normally expressed and has stable properties, and the current property and the current signal of the mutant are obviously improved.
Owner:JIANGXI INST OF TRANSLATIONAL MEDICINE

Method for obtaining tyrosine ammonialyase mutant based on high-throughput screening, tyrosine ammonialyase mutant and application of tyrosine ammonialyase mutant

The embodiment of the invention provides a method for obtaining a tyrosine ammonialyase mutant based on high-throughput screening, the tyrosine ammonialyase mutant and application of the tyrosine ammonialyase mutant. The mutant is subjected to any one of the following amino acid mutations on an amino acid sequence as shown in SEQ ID NO.2: A245G + A247T, and D192V + A245G + A247T. According to the embodiment of the invention, an amino acid sequence as shown in SEQ ID NO.2 is taken as a template (basis), a key active site of the template is subjected to mutation transformation, a mutant library is constructed, and a series of mutants with remarkably improved catalytic activity and / or conversion rate are screened; the tyrosine ammonia lyase mutant provided by the embodiment of the invention can selectively catalyze L-tyrosine to generate p-coumaric acid, and has excellent yield and / or higher yield, which indicates that the mutant has more significant application prospects in catalysis of L-tyrosine to generate p-coumaric acid.
Owner:SOUTH CHINA UNIV OF TECH

T7 RNA polymerase mutant and application thereof

The invention relates to a T7 RNA polymerase mutant and application thereof. Specifically, the invention discloses a T7 RNA polymerase mutant, and the polymerase mutant has at least one amino acid mutation at sites corresponding to a wild type T7 RNA polymerase and selected from the following groups: the 44th site, the 45th site, the 46th site, the 172nd site, the 389th site, the 425th site, the 441st site, the 632th site, the 643th site, the 754th site and the 789th site; the serial number of the mutation site is based on the sequence shown in SEQ ID NO: 1, the mutation leads to obvious reduction of a byproduct dsRNA generated in the process of enzyme synthesis of mRNA, and meanwhile, the generation of RNA aggregates is reduced.
Owner:NOVOPROTEIN SCI INC

Phosphate transketolase mutant and application thereof

The invention provides a phosphoketolase mutant and application thereof. Comprising the following steps: (a) compared with an amino acid sequence as shown in SEQ ID NO.1, the phosphoketolase mutant contains at least one of the following sites: H142, Q321 and E520, and an amino acid sequence which is subjected to amino acid mutation and has a phosphoketolase activity function; or (b) an amino acid sequence which is obtained by substitution and / or deletion and / or addition of one or more conserved amino acid residues of the phosphoketolase mutant and the amino acid sequence shown in (a) and has the same function. The invention provides a new way for converting C1-6 carbon sources into acetyl phosphate or acetyl coenzyme A without carbon loss. The catalytic activity of the phosphorylated transketolase mutant is higher than that of wild type phosphorylated transketolase.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Alcohol dehydrogenase mutant and application thereof

The invention relates to the field of biochemical engineering, in particular to an alcohol dehydrogenase mutant and application thereof. The mutant is obtained by mutating alcohol dehydrogenase with an amino acid sequence encoding SEQ ID NO: 4 at one or more sites selected from 62nd, 108th, 130th, 132, 134, 182nd, 206th, 287th, 303th, 313th and 314, and the mutation is that the amino acid at the site is mutated into one of A, G, V, L, I, P, F, Y, W, S, T, C, M, N, Q, D, E, K, R and H. According to the alcohol dehydrogenase mutant and the application of the alcohol dehydrogenase mutant, the feeding amount of substrates is increased; the high conversion rate (gt; 99%) of the substrate is realized; according to the present invention, the new YqjM has the good product ee value (gt; 98%), and it is determined that the YqjM derived from the bacillus subtilis old yellow enzyme (belonging to ketene reductase) has the optimal catalytic activity, such that the good industrial application performance is provided.
Owner:AURISCO PHARMACEUTICAL CO LTD +1

Carotenoid cleavage dioxygenase mutant and application thereof

The invention discloses a carotenoid cleavage dioxygenase mutant and application of the carotenoid cleavage dioxygenase mutant. The carotenoid cleavage dioxygenase mutant is subjected to any one or a combination of at least two of the following mutations on the basis of an amino acid sequence SEQ ID NO.1: F181G, F184L or F337M. According to the invention, the substrate beta-carotene is butted to a CCD4 enzyme activity pocket to construct a saturated mutant library, screening is carried out through a bacterial color complementation experiment, and after specific site amino acid mutation, degradation of the substrate beta-carotene is accelerated, thereby laying a certain technical foundation for further cultivation of new varieties of crops.
Owner:CHINA TOBACCO JIANGSU INDAL

P-coumaroyl coenzyme A 2 '-hydroxylase surface mutant and application thereof

The invention provides a p-coumaroyl coenzyme A 2 '-hydroxylase surface mutant and an application thereof. The p-coumaroyl coenzyme A 2 '-hydroxylase surface mutant is obtained by performing amino acid mutation on an amino acid sequence as shown in SEQ ID NO.1, and comprises at least one of the following amino acid mutations: A159K and E186K. The invention also provides an engineering bacterium which is constructed by using the p-coumarin coenzyme A 2 '-hydroxylase mutant and is used for synthesizing a coumarin compound, and the coumarin compound can be umbelliferone or daphnetin. The p-coumaroyl coenzyme A 2 '-hydroxylase mutant has good enzymatic activity and stability, and the enzymatic activity of the p-coumaroyl coenzyme A 2'-hydroxylase mutant is improved by 3.1 times or more, and even can be improved by 5.6 times; therefore, the engineering bacteria not only can realize efficient synthesis of coumarin compounds such as umbelliferone or daphnetin, but also can realize efficient de novo biosynthesis of the compounds such as umbelliferone or daphnetin.
Owner:BEIJING UNIV OF CHEM TECH

Data processing method and apparatus for virus protein mutation prediction

Embodiments of the present disclosure relate to virus protein mutation site discovery and variant design. There is proposed a data processing method for virus protein mutation prediction, comprising acquiring relevant information about a virus protein sequence for prediction, wherein the relevant information includes amino acid type information, amino acid position information, and corresponding fitness information in the virus protein sequence, and based on the relevant information about the virus protein sequence for prediction, predicting an amino acid mutation site in the virus protein sequence by using a neural network.
Owner:BEIJING YOUZHUJU NETWORK TECH CO LTD

Formaldehyde lyase as well as mutant and application thereof

The invention provides formaldehyde lyase as well as a mutant and application thereof. The amino acid sequence of the formaldehyde lyase mutant is shown as SEQ ID NO.1, SEQ ID NO.4 or SEQ ID NO.6 and contains at least one of the following sites: S26, W86, N87 or Y87, L109 or M109, L110, H281, Q282 or E282 and A460, and the amino acid sequence is subjected to amino acid mutation and has a formaldehyde lyase activity function. The amino acid sequences of the formaldehyde lyase and the mutants of the formaldehyde lyase have at least 99% of sequence identity with SEQ ID NO.1-7. The formaldehyde lyase and the mutant thereof can catalyze formaldehyde to synthesize 1, 3-dihydroxyacetone, and a new way for converting formaldehyde into 1, 3-dihydroxyacetone is provided.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Taq DNA polymerase mutant as well as preparation method and application thereof

The invention discloses a Taq DNA polymerase mutant as well as a preparation method and application thereof, and relates to the technical field of biology. The Taq DNA polymerase mutant is mutation on the basis of a wild type Taq DNA polymerase amino acid sequence as shown in SEQ ID NO.1, and comprises at least one of amino acid mutation L345E, L352D and S438M. The Taq DNA polymerase mutant has excellent tolerance to urea, and solves the dual technical problems that complex biological samples containing endogenous inhibitors such as urea can be efficiently amplified, and the Taq DNA polymerase mutant is compatible with difficult PCR reactions which take urea as an additive to optimize a high GC template and the like. Therefore, the mutant is a molecular biology tool enzyme which is wider in applicability and more stable and reliable in performance.
Owner:ZHUHAI BIORI BIOTECHNOLOGY CO LTD

Cyclodextrin glucosyltransferase mutant and application of cyclodextrin glucosyltransferase mutant in preparation of trehalose

The invention provides a cyclodextrin glucosyltransferase mutant and application thereof in preparation of trehalose, belongs to the technical field of gene engineering and enzyme engineering, and mainly provides the cyclodextrin glucosyltransferase mutant, amino acid mutation sites are 33rd and 21st amino acids of a cyclodextrin glucosyltransferase amino acid sequence SEQ ID NO.2; the disproportionation characteristic enzyme activity of the cyclodextrin glucosyltransferase mutant is obviously improved compared with that of a wild type, the thermal stability of the cyclodextrin glucosyltransferase mutant has obvious advantages, the optimum temperature of the mutant is 60 DEG C and is improved by 5 DEG C compared with that of the wild type, the cyclodextrin glucosyltransferase mutant is applied to preparation of trehalose through compounding of a multi-enzyme system, the yield of trehalose is obviously increased, and the application prospect is wide. The utilization rate of a substrate is increased, and meanwhile, the application prospect of the enzyme in medicine, food and biological industries is also improved.
Owner:QILU UNIVERSITY OF TECHNOLOGY (SHANDONG ACADEMY OF SCIENCES)

Method and system for improving affinity of antibody based on molecular dynamics and machine learning

The invention discloses a method and a system for improving antibody affinity based on molecular dynamics and machine learning, and belongs to the technical field of computer software. According to the method, a binding site of an antibody is accurately positioned by utilizing molecular dynamics, so that an optimal amino acid mutation site is screened out, a variant library of amino acid saturation mutation is constructed at the optimal amino acid mutation site, and the change quantity (# imgabs0 # value) of binding free energy of a mutant compound is calculated to serve as an evaluation basis; training a machine learning model by taking an amino acid descriptor as a feature and a # imgabs1 # value as a label, and screening out a model with optimal prediction performance; the model is used for predicting and screening mutants with a lower # imgabs2 # value (i.e., high affinity potential). The affinity of the high-affinity 1-7 single-domain antibody obtained by the method disclosed by the invention is remarkably improved by 2.98-5.04 times, so that the practicability and the high efficiency of the method are effectively verified, and a new way is opened up for the directed evolution of the single-domain antibody.
Owner:XIDIAN UNIV

Chenopodium quinoa willd CqARF2 gene mutant as well as identification method and application thereof

The invention discloses a quinoa CqARF2 gene mutant as well as an identification method and application thereof. Chenopodium quinoa seeds are mutated on a large scale by utilizing a chemical mutagenic agent EMS, a CqARF2 gene function deletion mutant arf2 is adopted as a quinoa mutant, G at the 1050th site of the CqARF2 gene of the mutant is mutated into A, and amino acid at the 350th site is mutated into a termination codon, so that the translation process of CqARF2 protein is terminated in advance. The chenopodium quinoa CqARF2 gene function deletion mutant arf2 shows remarkable agronomic character improvement, seeds are large and full, compared with a wild type, the hundred-grain weight of the mutant seeds is increased by about 40%, the seed diameter is increased by about 10%, the seed thickness is increased by about 30%, and a certain foundation is laid for breeding new high-yield and high-quality chenopodium quinoa varieties.
Owner:HANGZHOU NORMAL UNIVERSITY

Formate dehydrogenase mutant and application thereof

The invention provides a formate dehydrogenase mutant and application thereof. The formate dehydrogenase mutant comprises: (a) a protein having an amino acid sequence as shown in SEQ ID NO: 1; or (b) at least one of the following sites of the amino acid sequence in (a): A10, C23, K47, E53, I103, K109, V120, H148, V152, A168, L184, N187, E202, F285, Q287, T321 or K328, is subjected to amino acid mutation and has a formate dehydrogenase activity function, or (b) at least one of the following sites of the amino acid sequence in (a): A10, C23, K47, E53, I103, K109, V120, H148, V152, A168, L184, N187, E202, F285, Q287, T321 or K328; (c) protein which has more than 80% of homology with the amino acid sequence limited by any one of (a) and (b) and has a formate dehydrogenase function. The formate dehydrogenase mutant disclosed by the invention has better tolerance and higher activity under extreme conditions, can be better used for industrial amplification, and is low in cost and high in yield.
Owner:TIANJIN ASYMCHEM BIOTECHNOLOGY CO LTD

Application of T lymphocyte embedded with B7-H3 receptor in treatment of head and neck tumors

The invention relates to the field of tumor cell therapy, in particular to application of T lymphocyte chimeric with a B7-H3 receptor to treatment of head and neck tumors, and provides an anti-B7-H3 scFv, the scFv comprises a heavy chain variable region and a light chain variable region, the heavy chain variable region comprises an HCDR region and an HFR region, and the light chain variable region comprises an LCDR region and an LFR region; compared with a wild type scFv sequence, the scFv sequence has the advantage that a plurality of amino acids with positive charges in the HFR region and / or the LFR region are mutated into amino acids without charges. According to the invention, positive charge plaques on the CAR surface of an scFv sequence of a B7-H3 human-derived monoclonal antibody MGA271 are changed in a charged amino acid mutation manner, so that a B7-H3. CAR-T cell is optimized, and it is proved that the B7-H3. CAR-T cell optimized by PCP can effectively kill B7-H3 positive tumor cells in vivo and in vitro; and a new method and thought are provided for clinical targeted treatment of B7-H3 positive solid tumors.
Owner:EYE & ENT HOSPITAL SHANGHAI MEDICAL SCHOOL FUDAN UNIV

Mutant of RSV (Respiratory Syndrome Virus) pre-fusion conformation F protein and application thereof

PendingCN119431524AInhibition transitionconformational stabilitySsRNA viruses negative-senseViral antigen ingredientsDisulfide bondingF protein
The invention relates to a mutant of an RSV pre-fusion conformation F protein, the mutant comprises amino acid mutation relative to an amino acid sequence of a wild type RSV F protein, the amino acid mutation is that amino acids at positions 392 and 493 or near the 493 are substituted by C, and a disulfide bond is formed between mutated positions 392C and 493C or near the 493C. The invention also provides a related DNA (deoxyribonucleic acid) coding sequence, a recombinant plasmid, an mRNA (messenger ribonucleic acid) sequence and a corresponding RSV vaccine. By introducing disulfide bonds at proper positions and combining with cavity filling, electrostatic mutation, proline mutation and the like, the expression and stability of the F protein with conformations before and after fusion and trimerization conformations are remarkably improved, and the F protein is remarkably inhibited from being converted into conformations after fusion. The mutant is also applied to preparation of RSV vaccines and detection of respiratory syncytial virus infection.
Owner:BEIJING NEOCURNA BIOTECHNOLOGY CORP +2

Novel coronavirus variation analysis method

The invention discloses a novel coronavirus variation analysis method, belongs to the technical field of virus analysis and detection, and aims to solve the problem of how to quickly analyze virus variation in the prior art. The main method comprises the following steps: carrying out nucleic acid extraction and detection recheck on the novel coronavirus; carrying out whole genome targeted amplification on the novel coronavirus; carrying out whole genome sequencing on the novel coronavirus; carrying out genetic typing on the novel coronavirus; performing sequence quality evaluation on the obtained fasta file, and screening the sequence; and carrying out nucleotide and amino acid mutation site analysis on the screened high-quality sequence. According to the invention, the strain variation rule is analyzed from gene and protein molecule levels, and the influence of key variation on virus propagation and adaptability can be predicted according to the variation rule; tools used in the variation method are all existing tools, the actual effect can be well improved, and rapid preliminary variation analysis is provided.
Owner:SHENZHEN INT TRAVEL HEALTHCARE CENT

α-Amino acid ester acyltransferase mutant and its application

The present invention provides an α-amino acid ester acyltransferase mutant and its application. The α-amino acid ester acyltransferase mutant includes: (a) a protein having the amino acid sequence shown in SEQ ID NO: 1; (b) a protein having an amino acid mutation at at least one of the following sites in the amino acid sequence in (a): P158, K80, T208, A302, A175, N85, N605, K346, S225, I34, or S348, and having the function of an α-amino acid ester acyltransferase; or (c) a protein having more than 80% homology with the amino acid sequence defined in (a) or (b) and having the function of an α-amino acid ester acyltransferase. The α-amino acid ester acyltransferase mutant of the present invention has the advantages of a broad substrate spectrum and high catalytic activity, can be well used in the synthesis of oligopeptides, has low cost and high yield, and realizes true green chemistry.
Owner:TIANJIN ASYMCHEM BIOTECHNOLOGY CO LTD

Zearalenone toxin degrading enzyme with improved enzyme activity and application thereof

The invention belongs to the technical field of bioengineering, and particularly relates to a zearalenone toxin degrading enzyme variant and application thereof. The amino acid sequence of the zearalenone toxin degrading enzyme is as shown in SEQ ID NO.2, or the zearalenone toxin degrading enzyme with the amino acid sequence as shown in SEQ ID NO.2 is obtained through amino acid mutation. The zearalenone toxin degrading enzyme mutant is obtained through mutation screening, and compared with a wild type, the zearalenone toxin degrading enzyme mutant has the advantages that the zearalenone degrading capability is obviously improved; besides, the zearalenone toxin degrading enzyme is expressed by using alfalfa, the zearalenone toxin degrading enzyme with biological activity is easy to obtain, and the zearalenone toxin degrading enzyme has certain application potential in prevention and treatment of animal poisoning caused by zearalenone toxin pollution in agriculture and animal husbandry production.
Owner:JIANGSU SANYI BIO-ENG CO LTD +2

Daptomycin high-yield engineering strain with high capric acid tolerance as well as construction and application of daptomycin high-yield engineering strain

The invention discloses a daptomycin high-yield engineering strain with high capric acid tolerance as well as construction and application of the daptomycin high-yield engineering strain. According to the invention, a DptE mutant protein is obtained through amino acid mutation on the basis of a DptE protein, and the DptE mutant protein comprises one of a DptE mutant protein DptE:: K454I, a DptE mutant protein DptE:: K454R and a DptE mutant protein DptE:: K454I: Q420N: K184Q; according to the invention, a DptE protein coding gene in streptomyces roseosporus is replaced by a DptE mutant protein coding gene, and a TagR protein coding gene is knocked out, so that a daptomycin high-yield engineering strain is constructed. According to the method, the defects of long cycle and large manpower and material resource consumption of traditional mutation breeding are overcome, the production cost of daptomycin is greatly reduced, and the method has important application value in the industrial production process.
Owner:ZHEJIANG UNIV

High-temperature-resistant MMLV reverse transcriptase mutant and application thereof

The invention discloses a high-temperature-resistant MMLV reverse transcriptase mutant and application thereof. According to the high-temperature-resistant MMLV reverse transcriptase mutant, amino acid site mutation is carried out on the basis of a wild type MMLV reverse transcriptase amino acid sequence as shown in SEQ ID NO: 1; the amino acid mutation site comprises one or more of H126E, F199L, T246H, W388R, A404N and D422E, and the amino acid mutation site comprises one or more of H126E, F199L, T246H, W388R, A404N and D422E. Compared with a wild type, the high-temperature-resistant MMLV reverse transcriptase mutant prepared by the invention has the advantages of high specific enzyme activity and high thermal stability.
Owner:ACCURATE BIOTECHNOLOGY(HUNAN) CO LTD

Tyrosine ammonialyase mutant and application thereof in synthesis of p-hydroxycinnamic acid

According to the tyrosine ammonia lyase mutant, wild type tyrosine ammonia lyase amino acid is mutated into G182I / E472Q, and the enzyme activity of the tyrosine ammonia lyase mutant is improved to 258% compared with that of the wild type tyrosine ammonia lyase. Plasmids containing the tyrosine ammonia lyase mutant genes are transformed into escherichia coli, and recombinant engineering bacteria are obtained. The expressed tyrosine ammonia lyase mutant is used for catalyzing tyrosine to synthesize p-hydroxycinnamic acid. The optimal catalytic reaction conditions are as follows: the optimal thallus concentration of the recombinant engineering bacteria is 50g / L, the temperature is 50 DEG C, and the pH value is 8.5. Therefore, the reaction synthesis efficiency of the key raw material p-hydroxycinnamic acid of the photoresist resin monomer is improved.
Owner:BONTAC BIO ENG (SHENZHEN) CO LTD

Nitrile hydratase mutant and use thereof

A nitrile hydratase mutant and the use thereof. The nitrile hydratase mutant is a wild-type nitrile hydratase having a mutation of an amino acid residue in the flexible loop domain, and comprises any one of or a combination of mutations 1-3, wherein mutation 1 is a polar amino acid mutation located in the flexible loop between secondary domains S1 and S2 of the β subunit of the wild-type nitrile hydratase; mutation 2 is a polar amino acid mutation located in the flexible loop between secondary domains H6 and H7 at the starting end of the β subunit of the wild-type nitrile hydratase; and mutation 3 is a hydrophobic amino acid mutation in starting flexible loop L1 of the β subunit of the wild-type nitrile hydratase. On the basis of the wild-type nitrile hydratase, the nitrile hydratase mutant can comprise any one of or a combination of the mutations described above, which can exert regulatory effects alone or synergistically, has a certain enzyme activity, and has good thermal stability and tolerance.
Owner:TSINGHUA UNIVERSITY +1

Pfago mutant protein having target nucleic acid cleavage activity at medium temperatures and use thereof

Provided are a PfAgo mutant protein having target nucleic acid cleavage activity at medium temperatures and a use thereof. The PfAgo mutant protein has an amino acid mutation at position 617 and / or position 618 relative to the sequence as shown in SEQ ID NO. 1, specifically, K617E / G and / or L618Y / F / W / G. Compared with a wild-type PfAgo protein, the provided PfAgo mutant protein has activity in a temperature range of 30-95°C, and thus, the scope of use of the pAgo protein is effectively expanded.
Owner:HUBEI UNIV

Transformation method and application of G protein coupled receptor

The invention discloses a transformation method and application of a G protein coupled receptor, and belongs to the technical field of protein engineering. In order to improve the molecular weight of membrane protein, enable the enlarged part of the membrane protein and the original membrane protein to form a relatively rigid structure and further meet the structural analysis requirement of a cryoelectron microscope, the invention provides a method for transforming a G protein coupled receptor. The method comprises the following steps: co-expressing fusion protein GPCR (Glycine Polymerase Chain Reaction)-GFP10-11 and GFP1-9 fragments formed by GPCR and GFP10-11 fragments in a eukaryotic cell expression system, and adding GFP-clamp in the purification process; one amino acid at the specific site of GPCR is mutated into cysteine, glutamic acid at the 186th position of the amino acid sequence of GFP-clamp is mutated into cysteine, and a disulfide bond is formed between the amino acid and glutamic acid. The molecular weight of the modified G protein coupled receptor obtained by using the method can be increased to 85 kD or above, and the rigidity of the whole compound space structure is relatively strong, so that the modified G protein coupled receptor can be used for structural analysis of a cryoelectron microscope.
Owner:ALPHELIX BIOTECH CO LTD

Cetuximab variants targeting epidermal growth factor receptor resistance mutants

The invention discloses a cetuximab variant CtxD103R of a targeted epidermal growth factor receptor drug-resistant mutant EGFRK489E (epidermal growth factor receptor). The cetuximab variant is obtained based on the rational design of wild type cetuximab. According to the present invention, the specific amino acid mutation D103R is performed on the heavy chain sequence of the wild type cetuximab, and the affinity experiment and the functional experiment are combined to research the influence of the mutated cetuximab variant CtxD103R on the drug resistance mutation EGFRK489E so as to finally prove that the cetuximab variant CtxD103R can be well combined with the EGFRK489E mutant, such that the EGFR phosphorylation can be hindered, and the EGFRK489E can be inhibited; the influence of the drug-resistant mutation K489E is weakened. The cetuximab variant CtxD103R disclosed by the invention lays a good foundation for research on resistance to drug-resistant mutation. The antibody has a wide application prospect in the field of tumor prevention and / or treatment.
Owner:ZHEJIANG UNIV